Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
Oncology Today with Dr Neil Love - A podcast by Research To Practice
Categories:
Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma. CME information and select publications here
